Back to Search
Start Over
sj-docx-1-tam-10.1177_17588359221142786 – Supplemental material for A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study): primary analysis
- Publication Year :
- 2022
- Publisher :
- SAGE Journals, 2022.
-
Abstract
- Supplemental material, sj-docx-1-tam-10.1177_17588359221142786 for A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study): primary analysis by Hisashi Tanaka, Shigeru Tanzawa, Toshihiro Misumi, Tomonori Makiguchi, Megumi Inaba, Takeshi Honda, Junya Nakamura, Koji Inoue, Takayuki Kishikawa, Masanao Nakashima, Keiichi Fujiwara, Tadashi Kohyama, Hiroo Ishida, Shoichi Kuyama, Naoki Miyazawa, Tomomi Nakamura, Hiroshi Miyawaki, Naohiro Oda, Nobuhisa Ishikawa, Ryotaro Morinaga, Kei Kusaka, Nobukazu Fujimoto, Yasushi Fukuda, Masayuki Yasugi, Takeshi Tsuda, Sunao Ushijima, Kazuhiko Shibata, Takuo Shibayama, Akihiro Bessho, Kyoichi Kaira, Kenshiro Shiraishi, Noriyuki Matsutani and Nobuhiko Seki in Therapeutic Advances in Medical Oncology
Details
- ISSN :
- 17588359
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....38e0a5ac010deeae1bf0cf3bd39b6cf4
- Full Text :
- https://doi.org/10.25384/sage.21754026